Cargando…

(1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites

BACKGROUND: Metabolomic profiling of human malignant effusion remain a field poorly investigated. Proton nuclear magnetic resonance ((1)H-NMR) spectroscopy is a rapid relatively low cost technique, and effusion is an optimal biospecimen suitable for metabonomic investigations. With this study we add...

Descripción completa

Detalles Bibliográficos
Autores principales: Zennaro, Lucio, Nicolè, Lorenzo, Vanzani, Paola, Cappello, Filippo, Fassina, Ambrogio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292235/
https://www.ncbi.nlm.nih.gov/pubmed/32566728
http://dx.doi.org/10.1515/pp-2020-0113
_version_ 1783546068215005184
author Zennaro, Lucio
Nicolè, Lorenzo
Vanzani, Paola
Cappello, Filippo
Fassina, Ambrogio
author_facet Zennaro, Lucio
Nicolè, Lorenzo
Vanzani, Paola
Cappello, Filippo
Fassina, Ambrogio
author_sort Zennaro, Lucio
collection PubMed
description BACKGROUND: Metabolomic profiling of human malignant effusion remain a field poorly investigated. Proton nuclear magnetic resonance ((1)H-NMR) spectroscopy is a rapid relatively low cost technique, and effusion is an optimal biospecimen suitable for metabonomic investigations. With this study we addressed metabolomic profiling of malignant ascitic effusion (mAE) from patients with high grade serous ovarian carcinoma (HGSOC), Hepatocellular carcinoma (HCC), and benign AEs (bAEs) from patients with reactive peritonitis. METHODS: Metabolic profiling with (1)H-NMR was performed on 72 AEs (31 HGSOC, 16 HCC and 25 bAE) prospectively collected in our cytology service. Histological confirmation was requested for all malignant case. Multivariate analysis comprising PCA and PLS-DA was applied to discover metabolites suitable to differentiate effusions among the investigated groups. RESULTS: (1)H-NMR metabonomic analysis showed clearly different spectra for malignant and benign AEs, as well as for HGSOC vs. HCC effusion. When compared with HCC effusions, the HGSOC effusion were enriched, among all, in alanine, lipids, N-acetyl groups and phenylalanine and depleted in glutamine. CONCLUSIONS: Subject to validation in further larger studies, (1)H-NMR metabonomics could be an effective and reliable ancillary tool for AE investigations and diagnosis particularly in acellular effusions.
format Online
Article
Text
id pubmed-7292235
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-72922352020-06-18 (1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites Zennaro, Lucio Nicolè, Lorenzo Vanzani, Paola Cappello, Filippo Fassina, Ambrogio Pleura Peritoneum Research Article BACKGROUND: Metabolomic profiling of human malignant effusion remain a field poorly investigated. Proton nuclear magnetic resonance ((1)H-NMR) spectroscopy is a rapid relatively low cost technique, and effusion is an optimal biospecimen suitable for metabonomic investigations. With this study we addressed metabolomic profiling of malignant ascitic effusion (mAE) from patients with high grade serous ovarian carcinoma (HGSOC), Hepatocellular carcinoma (HCC), and benign AEs (bAEs) from patients with reactive peritonitis. METHODS: Metabolic profiling with (1)H-NMR was performed on 72 AEs (31 HGSOC, 16 HCC and 25 bAE) prospectively collected in our cytology service. Histological confirmation was requested for all malignant case. Multivariate analysis comprising PCA and PLS-DA was applied to discover metabolites suitable to differentiate effusions among the investigated groups. RESULTS: (1)H-NMR metabonomic analysis showed clearly different spectra for malignant and benign AEs, as well as for HGSOC vs. HCC effusion. When compared with HCC effusions, the HGSOC effusion were enriched, among all, in alanine, lipids, N-acetyl groups and phenylalanine and depleted in glutamine. CONCLUSIONS: Subject to validation in further larger studies, (1)H-NMR metabonomics could be an effective and reliable ancillary tool for AE investigations and diagnosis particularly in acellular effusions. De Gruyter 2020-05-12 /pmc/articles/PMC7292235/ /pubmed/32566728 http://dx.doi.org/10.1515/pp-2020-0113 Text en © 2020 Zennaro et al., published by De Gruyter http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 Public License.
spellingShingle Research Article
Zennaro, Lucio
Nicolè, Lorenzo
Vanzani, Paola
Cappello, Filippo
Fassina, Ambrogio
(1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
title (1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
title_full (1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
title_fullStr (1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
title_full_unstemmed (1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
title_short (1)H-NMR spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
title_sort (1)h-nmr spectroscopy metabonomics of reactive, ovarian carcinoma and hepatocellular carcinoma ascites
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292235/
https://www.ncbi.nlm.nih.gov/pubmed/32566728
http://dx.doi.org/10.1515/pp-2020-0113
work_keys_str_mv AT zennarolucio 1hnmrspectroscopymetabonomicsofreactiveovariancarcinomaandhepatocellularcarcinomaascites
AT nicolelorenzo 1hnmrspectroscopymetabonomicsofreactiveovariancarcinomaandhepatocellularcarcinomaascites
AT vanzanipaola 1hnmrspectroscopymetabonomicsofreactiveovariancarcinomaandhepatocellularcarcinomaascites
AT cappellofilippo 1hnmrspectroscopymetabonomicsofreactiveovariancarcinomaandhepatocellularcarcinomaascites
AT fassinaambrogio 1hnmrspectroscopymetabonomicsofreactiveovariancarcinomaandhepatocellularcarcinomaascites